Publication: 3771

Publication: 3771

Alliance A059102: A Randomized Phase II US Intergroup Study of CHO(E)P vs CC-486-CHO(E)P vs DUVELISIB-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

URL

Google Scholar

Citation:

Meeting Instance:: IUCLS 2022
Year:: 2022
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG)

Corr. Author:
Authors:: Neha Mehta-Shah Susan Geyer Nancy Bartlett Stefan Barta Jennifer Amengual Travis Dockter Chadwick Wright Eric Hsi Shira N. Dinner Steven Horwitz Brad Kahl Jonathan Friedberg John Leonard

Networks:

Study: Alliance-A051902
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: